GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Akums Drugs and Pharmaceuticals Ltd (BOM:544222) » Definitions » 3-Year ROIIC %

Akums Drugs and Pharmaceuticals (BOM:544222) 3-Year ROIIC % : -18.68% (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Akums Drugs and Pharmaceuticals 3-Year ROIIC %?

3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year. Akums Drugs and Pharmaceuticals's 3-Year ROIIC % for the quarter that ended in Mar. 2024 was -18.68%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Akums Drugs and Pharmaceuticals's 3-Year ROIIC % or its related term are showing as below:

BOM:544222's 3-Year ROIIC % is ranked worse than
71.67% of 999 companies
in the Drug Manufacturers industry
Industry Median: 0.92 vs BOM:544222: -18.68

Akums Drugs and Pharmaceuticals 3-Year ROIIC % Historical Data

The historical data trend for Akums Drugs and Pharmaceuticals's 3-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Akums Drugs and Pharmaceuticals 3-Year ROIIC % Chart

Akums Drugs and Pharmaceuticals Annual Data
Trend Mar21 Mar22 Mar23 Mar24
3-Year ROIIC %
- - - -18.68

Akums Drugs and Pharmaceuticals Semi-Annual Data
Mar21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24
3-Year ROIIC % Get a 7-Day Free Trial - - - -18.68 -

Competitive Comparison of Akums Drugs and Pharmaceuticals's 3-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Akums Drugs and Pharmaceuticals's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Akums Drugs and Pharmaceuticals's 3-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Akums Drugs and Pharmaceuticals's 3-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Akums Drugs and Pharmaceuticals's 3-Year ROIIC % falls into.



Akums Drugs and Pharmaceuticals 3-Year ROIIC % Calculation

Akums Drugs and Pharmaceuticals's 3-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

3-Year ROIIC %=3-Year Incremental Net Operating Profit After Taxes (NOPAT)**/3-Year Incremental Invested Capital**
=( -62.622425999999 (Mar. 2024) - 1645.52858 (Mar. 2021) )/( 26122.33 (Mar. 2024) - 16976.82 (Mar. 2021) )
=-1708.151006/9145.51
=-18.68%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Akums Drugs and Pharmaceuticals  (BOM:544222) 3-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Akums Drugs and Pharmaceuticals 3-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Akums Drugs and Pharmaceuticals's 3-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Akums Drugs and Pharmaceuticals Business Description

Comparable Companies
Traded in Other Exchanges
Address
Akums House, Plot No. 131 to 133, Block C, Mangolpuri Industrial Area Phase1, Adjoining CBSE Office, Delhi, IND, 110083
Akums Drugs and Pharmaceuticals Ltd a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas. Its services include formulation research and development (R&D), preparation and filing of regulatory dossiers in the Indian and Outside markets, and other testing services. It is also engaged in the manufacturing and sale of branded pharmaceutical formulations and active pharmaceutical ingredients (APIs). The operates in three segments: a) Contract Development and Manufacturing Operations (CDMO), b) Active Pharmaceutical Ingredient (API), and c) Branded and Generic formulations. Key revenue is generated from Contract Development and Manufacturing Operations (CDMO).

Akums Drugs and Pharmaceuticals Headlines

No Headlines